Search results
VacZine Analytics Ltd (Assay Advantage)
VacZine Analytics is an established strategic research publisher based in the United Kingdom. GeneScope Intelligence is also trading brand of Assay Advantage Ltd (UK Company No. 5807728), publisher of Gene Scope Intelligence and sister brand to VacZine Analytics, a UK-based strategic research publisher operating since 2007.
Welbeck
Welbeck Cambridge: Bringing Pioneering Healthcare to Cambridge in 2027 We're thrilled to announce that Welbeck Health Partners is coming to Cambridge in 2027. As a leading provider of private healthcare, we're committed to delivering the best possible patient experience through minimally invasive surgery, outpatient…
Wellbeing at Work
Better mental health. Stronger teams. Wellbeing at Work delivers practical, evidence-informed mental health and wellbeing training that helps organisations equip their people with the skills and confidence to build healthier, more sustainable workplaces.
Wellcome MRC Cambridge Stem Cell Institute
The Cambridge Stem Cell Institute is a world-leading centre for stem cell research with a mission to transform human health through a deep understanding of stem cell biology.
Wellcome Sanger Institute
The Wellcome Sanger Institute is a world-leading genomics research centre, based on the Wellcome Genome Campus, arguably the largest single-site community of expertise in Genomes and BioData in the world. We undertake large-scale research that forms the foundations of knowledge in biology and medicine. We are open and collaborative; our data,…
Xiomed
Xiomed supports early-stage MedTech companies to navigate product development, regulatory affairs and manufacturing operations challenges. We do so by providing strategic advice and planning to achieve clarity and confidence. This ensures our clients utilise their precious funds and resources to create maximum value.
Zyme Communications
Zyme Communications provides PR and marketing services for the life science sector. We support companies to raise their profile, build corporate value and generate interest from commercial leads, investors and partners.






